Is histological diagnosis of primary liver carcinomas with fibrous stroma reproducible among experts?

Journal of Clinical Pathology

Volumn 62, Issue 6, 2009, Pages 519-524

  Malouf, G ^a   Falissard, B ^b   Azoulay, D ^b   Callea, F ^c   Ferrell, L D ^d   Goodman, Z D ^e   Hayashi, Y ^f   Hsu, H C ^g   Hubscher, S G ^h   Kojiro, M ⁱ   Ng, I O ^j   Paterson, A C ^k   Reynes, M ^b   Zafrani, E S ^l   Emile, Jean François ^a,m  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b HÔPITAL PAUL BROUSSE   (France)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^f Faculty of Medicine   (Japan)

^g NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^h UNIVERSITY OF BIRMINGHAM   (United Kingdom)

ⁱ KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j UNIVERSITY OF HONG KONG   (Hong Kong)

^k UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^l HENRI MONDOR HOSPITAL   (France)

^m HÔPITAL AMBROISE PARÉ   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19; CYTOKERATIN 7;

ADOLESCENT; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; OBSERVER VARIATION; PRIORITY JOURNAL; REPRODUCIBILITY; SCHOOL CHILD; STROMA;

ADOLESCENT; ADULT; AGED; ANTIBODIES; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, HEPATOCELLULAR; CHILD; CHOLANGIOCARCINOMA; CLUSTER ANALYSIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-19; KERATIN-7; KERATINS; LIVER NEOPLASMS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 67649199417     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2008.062620     Document Type: Article

References (34)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827-841
2. McGlynn KA, Tsao L, Hsing AW, et al. International trends and patterns of primary liver cancer. Int J Cancer 2001;94:290-296
3. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Liver Cancer Study Group of Japan. Ann Surg 1990;211:277-287
4. Kaczynski J, Hansson G, Wallerstedt S. Incidence, etiologic aspects and clinicopathologic features in intrahepatic cholangiocellular carcinoma - a study of 51 cases from a low-endemicity area. Acta Oncol 1998;37:77-83.
5. Hellerbrand C, Hartmann A, Richter G, et al. Hepatocellular carcinoma in southern Germany: epidemiological and clinicopathological characteristics and risk factors. Dig Dis 2001;19:345-351
6. Nakajima T, Kondo Y, Miyazaki M, et al. A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading. Hum Pathol 1988;19:1228-1234
7. Yamanaka N, Okamoto E, Ando T, et al. Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma. Cancer 1995;76:2449-2456
8. Craig JR, Peters RL, Edmondson HA, et al. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 1980;46:372-379
9. Omata M, Peters RL, Tatter D. Sclerosing hepatic carcinoma: relationship to hypercalcemia. Liver 1981;1:33-49.
10. Buchanan TF Jr, Huvos AG. Clear-cell carcinoma of the liver. A clinicopathologic study of 13 patients. Am J Clin Pathol 1974;61:529-539
11. Emile JF, Lemoine A, Azoulay D, et al. Histological, genomic and clinical heterogeneity of clear cell hepatocellular carcinoma. Histopathology 2001;38:225-231
12. Emile JF, Adam R, Sebagh M, et al. Hepatocellular carcinoma with lymphoid stroma: a tumour with good prognosis after liver transplantation. Histopathology 2000;37:523-529
13. Okuda K. Natural history of hepatocellular carcinoma including fibrolamellar and hepato-cholangiocarcinoma variants. J Gastroenterol Hepatol 2002;17:401-405
14. Ng IO, Shek TW, Nicholls J, et al. Combined hepatocellular- cholangiocarcinoma: a clinicopathological study. J Gastroenterol Hepatol 1998;13:34-40.
15. Jarnagin WR, Weber S, Tickoo SK, et al. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer 2002;94:2040-2046
16. LaCasce AS, Kho ME, Friedberg JW, et al. Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer Network. J Clin Oncol 2008;26:5107-5112
17. Zam NA, Tan PH, Sim HG, et al. Correlation between prostate needle biopsies and radical prostatectomy specimens: can we predict pathological outcome? Pathology 2008;40:586-591
18. Verghese ET, den Bakker MA, Campbell A, et al. Interobserver variation in the classification of thymic tumours - a multicentre study using the WHO classification system. Histopathology 2008;53:218-223
19. Evans AJ, Henry PC, Van der Kwast TH, et al. Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimens. Am J Surg Pathol 2008;32:1503-1512
20. Jones J, Hunter D. Consensus methods for medical and health services research. BMJ 1995;311:376-380
21. Fuller GN, Hess KR, Rhee CH, et al. Molecular classification of human diffuse gliomas by multidimensional scaling analysis of gene expression profiles parallels morphology-based classification, correlates with survival, and reveals clinicallyrelevant novel glioma subsets. Brain Pathol 2002;12:108-116
22. Loze JY, Falissard B, Limosin F, et al. Validation of a new diagnostic procedure for DSM IV axis I disorders. Int J Methods Psychiatr Res 2002;11:134-141
23. Shmulevich I, Zhang W. Binary analysis and optimization-based normalization of gene expression data. Bioinformatics 2002;18:555-565
24. Borg I, Groenen P. Modern multidimensional scaling: theory and applications. New York: Springer-Verlag, 1977.
25. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-1392
26. Department of Statistics and Mathematics, WU Wien. The R project for statistical computing. http://www.r-project.org/ (accessed 17 February 2009).
27. Schlemper RJ, Itabashi M, Kato Y, et al. Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists. Lancet 1997;349:1725-1729
28. Farmer ER, Gonin R, Hanna MP. Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol 1996;27:528-531
29. Sloane JP, Amendoeira I, Apostolikas N, et al. Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology. Hum Pathol 1998;29:1056-1062
30. Edmondson HA. Differential diagnosis of tumors and tumorlike lesion of liver in infancy and childhood. Arch Dis Child 1956;1:168-181
31. Okada S, Shimada K, Yamamoto J, et al. Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 1994;106:1618-1624
32. Nzeako UC, Goodman ZD, Ishak KG. Comparison of tumor pathology with duration of survival of North American patients with hepatocellular carcinoma. Cancer 1995;76:579-588
33. Lau H, Fan ST, Ng IO, et al. Long term prognosis after hepatectomy for hepatocellular carcinoma: a survival analysis of 204 consecutive patients. Cancer 1998;83:2302-2311
34. Komuta M, Spee B, Vander Borght S, et al. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology 2008;47:1544-1556